Managing hot flushes in men receiving androgen deprivation therapy for prostate cancer

被引：5
|
作者：
Khan, Atia [1 ]
Lewis, Rachel [1 ]
Hughes, Simon [2 ,3 ]
机构：
[1] Univ Coll Hosp, Clin Oncol, London, England
[2] Guys & St Thomas Hosp NHS Trust, London, England
[3] Kings Coll London, Dept Imaging Sci, London, England
来源：
TRENDS IN UROLOGY & MENS HEALTH | 2014年 / 5卷 / 01期
关键词：
D O I：
10.1002/tre.377
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
In this series, the authors present cases of men being treated with androgen deprivation therapy, and highlight management strategies to prevent and treat associated toxicities. In this fourth article, the authors consider the management of hot flushes.
引用
收藏
页码：31 / 33
页数：3
相关论文
共 50 条
  • [41] Cognitive impairment in men receiving androgen deprivation therapy for prostate cancer as compared to healthy controls
    Estrella, Timothy J.
    Jim, Heather S.
    Small, Brent J.
    Patterson, Stephen G.
    Jacobsen, Paul B.
    ANNALS OF BEHAVIORAL MEDICINE, 2008, 35 : S18 - S18
  • [42] SEXUAL FUNCTION IN MEN RECEIVING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER: A LONGITUDINAL CONTROLLED COMPARISON
    Donovan, Kristine A.
    Cessna, Julie M.
    Cases, Mallory
    Jacobsen, Paul B.
    ANNALS OF BEHAVIORAL MEDICINE, 2014, 47 : S105 - S105
  • [43] Risk Factors for Bone Loss with Prostate Cancer in Korean Men Not Receiving Androgen Deprivation Therapy
    Kim, Sun-Ouck
    Kang, Taek Won
    Kwon, Dongdeuk
    Park, Kwangsung
    Ryu, Soo Bang
    INTERNATIONAL BRAZ J UROL, 2009, 35 (02): : 183 - 188
  • [44] Re: Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
    Langley, Ruth E.
    Cafferty, Fay H.
    Pollock, Philip A.
    Price, Patricia
    Abel, Paul D.
    JOURNAL OF UROLOGY, 2011, 185 (06): : 2430 - 2431
  • [45] Effect of Diphosphonates on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
    Wu, Congcong
    Chen, Wenjun
    Huang, Xuanzhang
    Lin, Ruifang
    Wu, Jian
    Zhang, Xi
    CLINICAL GENITOURINARY CANCER, 2018, 16 (06) : E1243 - E1250
  • [46] Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
    Smith, Matthew R.
    Saad, Fred
    Egerdie, Blair
    Szwedowski, Maciej
    Tammela, Teuvo L. J.
    Ke, Chunlei
    Leder, Benjamin Z.
    Goessl, Carsten
    JOURNAL OF UROLOGY, 2009, 182 (06): : 2670 - 2675
  • [47] NATURAL HISTORY OF BONE LOSS IN MEN WITH PROSTATE CANCER RECEIVING ANDROGEN-DEPRIVATION THERAPY
    Saad, Fred
    Feldman, Robert
    Heracek, Jiri
    Ke, Chunlei
    Goessi, Carsten
    JOURNAL OF UROLOGY, 2009, 181 (04): : 593 - 594
  • [48] Androgen deprivation therapy and risk of diabetes mellitus in men undergoing androgen deprivation therapy for prostate cancer
    Kincade, MC
    Derweesh, IH
    Malcolm, J
    Lamar, KD
    Patterson, AL
    Kitabchi, AE
    Wake, R
    JOURNAL OF UROLOGY, 2006, 175 (04): : 41 - 41
  • [49] PATIENTS RECEIVING ANDROGEN DEPRIVATION TREATMENT FOR PROSTATE CANCER: MANAGING SIDE EFFECTS
    Calvaresi, Anne
    Trabulsi, Edouard
    Miller, Janice
    Hong Truong
    Hurwitz, Mark
    JOURNAL OF UROLOGY, 2019, 201 (04): : E301 - E301
  • [50] Fracture risk in men with prostate cancer on androgen deprivation therapy
    Krupski, TL
    Smith, MR
    Lee, WC
    Pashos, CL
    Brandman, J
    Wang, Q
    Botteman, MF
    Litwin, MS
    JOURNAL OF UROLOGY, 2004, 171 (04): : 116 - 116
12345